Lyon, France (Oct 10) – The ACTION Global Health Advocacy Partnership applauds world leaders for pledging USD 13.92 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years (2020–2022), with a commitment by President Emmanuel Macron, Bill Gates and Bono to rally the final USD 100 million by December.
Washington, D.C. (Sept. 26) – In a major win for affected communities and advocates across the world, the first-ever United Nations High-Level Meeting (UNHLM) on Tuberculosis (TB) opened with firm commitments by leaders from all member states to reach 40 million people with treatment by 2022 and scale up global funding to US$13 billion per year for TB programs and $2 billion for research and development (R&D) annually in order to do so.
Global Fund report shows why leaders must commit to faster progress on TB
Washington D.C. (Sept. 12) - The Global Fund Results Report 2018, released today, demonstrates the remarkable successes that can be achieved when governments, the private sector, civil society, and affected communities work together to tackle some of society’s most intractable problems.
Washington, D.C. (March 22) – ACTION global health advocacy partnership is observing World Tuberculosis (TB) Day with new calls on world leaders to prioritize ending the disease. Caused by an airborne bacterium, TB is the world’s leading infectious disease killer, responsible for 1.7 million deaths per year and sickening more than 10 million in 2017.
Delhi, India (Mar. 13) - Health leaders from around the world gathered here today to fast track the fight to end tuberculosis. The day’s events included the formal launch by Prime Minister Modi of a strategy to end TB in India by 2025.
Washington, D.C. (Feb. 16) – ACTION, in a bid to end one of the world’s oldest and most infectious diseases, hosted its latest media champion training for tuberculosis (TB) survivors, advocates, and researchers in Paris, France, February 1 - 4. Accommodating 10 participants from 9 countries, the training, in its 11th year, sought to deepen and broaden the advocacy group’s effort to promote investment in TB research and treatment, and ultimately, to help eliminate the disease by 2030, the goal set by the World Health Organization.